Zellander, A. et al.
Zellander, A. et al. “Personalized Immunotherapeutic Platform, with Evidence of Clinical Activity in Glioblastoma, Protects Mice Against Ovarian, Liver & Bladder Cancer Tumor Challenges” Presented at SITC 2022.
Zellander, A. et al. “Personalized Immunotherapeutic Platform, with Evidence of Clinical Activity in Glioblastoma, Protects Mice Against Ovarian, Liver & Bladder Cancer Tumor Challenges” Presented at SITC 2022.